Key points are not available for this paper at this time.
Journal Article The DanGer Shock trial: a new dawn but much to uncover Get access Enzo Lüsebrink, Enzo Lüsebrink Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Pettenkoferstraße 8a/9, 80336 Munich, Germany Corresponding authors. Tel: +49 (0) 89 4400 72305, Email: E.Luesebrink@med.uni-muenchen.de (E.L.); Tel: +49 (0) 0341 865 1428, Email: Holger.Thiele@medizin.uni-leipzig.de (H.T.) https://orcid.org/0000-0002-3214-5672 Search for other works by this author on: Oxford Academic PubMed Google Scholar Leonhard Binzenhöfer, Leonhard Binzenhöfer Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Pettenkoferstraße 8a/9, 80336 Munich, Germany Search for other works by this author on: Oxford Academic PubMed Google Scholar Holger Thiele Holger Thiele Department of Internal Medicine/Cardiology and Leipzig Heart Science, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany Corresponding authors. Tel: +49 (0) 89 4400 72305, Email: E.Luesebrink@med.uni-muenchen.de (E.L.); Tel: +49 (0) 0341 865 1428, Email: Holger.Thiele@medizin.uni-leipzig.de (H.T.) https://orcid.org/0000-0002-0169-998X Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, ehae516, https://doi.org/10.1093/eurheartj/ehae516 Published: 12 August 2024
Lüsebrink et al. (2024) studied this question.